FMR LLC 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 10:32 am Purchase | 2024-11-08 | 13G | Janux Therapeutics, Inc. JANX | FMR LLC | 7,824,674 14.999% | 3,153,461 (+67.51%) | Filing |
| 2024-02-09 09:16 am Sale | 2024-02-08 | 13G | Janux Therapeutics, Inc. JANX | FMR LLC | 4,671,213 10.117% | -934,647 (-16.67%) | Filing |
| 2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | Janux Therapeutics, Inc. JANX | FMR LLC | 5,605,860 13.455% | 614,458 (+12.31%) | Filing |
| 2022-01-10 1:26 pm Purchase | 2022-01-07 | 13G | Janux Therapeutics, Inc. JANX | FMR LLC | 4,991,402 11.995% | 4,991,402 (New Position) | Filing |